Researchers at NYU Langone’s Resilience, Intersectional Stigma, and Empowerment Lab explore barriers to pre-exposure prophylaxis.

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

Despite significant advances in HIV prevention, Black women remain underserved and overexposed. Here’s what needs to change.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the ...

Professor Quarraisha Abdool Karim's election as a Fellow of the Royal Society underscores the importance of innovative ...